2′OMe |
2′-O-methyl |
ALL |
acute lymphoblastic leukemia |
AML |
acute myeloid leukemia |
B-ALL |
B-cell acute lymphoblastic leukemia |
BM |
bone marrow |
ceRNA |
competing endogenous RNA |
circRNA |
circular RNA |
GAS5 |
growth arrest-specific transcript 5 |
GR |
glucocorticoid receptor |
GRE |
glucocorticoid response element |
HdH |
high hyperdiploidy |
ID |
initial diagnosis |
lncRNA |
long non-coding RNA |
miRNA |
microRNA |
miscRNA |
miscellaneous RNA |
MRE |
miRNA response element |
ncRNA |
non-coding RNA |
NGS |
Next Generation Sequencing |
NH-HeH |
near-haploid and high hyperdiploid |
nt |
nucleotide |
PB |
peripheral blood |
PCA3 |
Prostate Cancer gene 3 |
Ph+ |
Philadelphia chromosome-positive |
pri-miRNA |
primary miRNA |
pre-miRNA |
precursor miRNA |
REL |
relapse |
RNA-Seq |
RNA-sequencing |
RNP |
ribonucleoprotein |
rRNA |
ribosomal RNA |
scaRNA |
Small Cajal body-specific RNA |
smRNA-Seq |
small RNA-sequencing |
SNP |
single-nucleotide polymorphism |
snoRNA |
small nucleolar RNA |
snRNA |
small nuclear RNA |
T-ALL |
T-cell acute lymphoblastic leukemia |
TARGET |
Therapeutically Applicable Research to Generate Effective Treatments |
TKI |
tyrosine kinase inhibitor |
tRNA |
transfer RNA |
WGS |
whole-genome sequencing |
WES |
whole-exome sequencing |